• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Drug Discovery | Pharma |News, Analysis, Insights - HIT Consultant

 

ArcaScience Raises $7M to Advance AI-Powered Drug Benefit-Risk Evaluation

by Fred Pennic 09/03/2025 Leave a Comment

ArcaScience Raises $7M to Advance AI-Powered Drug Benefit-Risk Evaluation

What You Should Know:  - ArcaScience, a Paris, France-based AI Healthtech startup, has announced a $7M seed funding round led by The Moon Venture, with participation from Pléiade Venture, Plug&Play Ventures, Bpifrance, and AKKA Technologies. This marks the company's first institutional funding round, following a €1.3 million pre-seed raise. - The new funds will be used to expand operations in the U.S. and U.K., launch the company’s first patient-facing solution, and strategically
Read More

Ginkgo, Tangible & Inductive Bio Launch AI-Powered Lab-in-the-Loop Drug Discovery

by Fred Pennic 08/21/2025 Leave a Comment

Ginkgo, Tangible & Inductive Bio Launch AI-Powered Lab-in-the-Loop Drug Discovery

What You Should Know:  - Ginkgo Bioworks has announced a new strategic partnership with Inductive Bio and Tangible Scientific to make AI-driven "lab-in-the-loop" drug discovery more accessible to the industry.  - The collaboration combines high-throughput experimental workflows, streamlined compound management, and predictive chemistry AI models into one seamless, integrated service. This is designed to help scientists discover better drugs with fewer resources by delivering
Read More

Certara Expands Partnership with Merck to Streamline Drug Development Data Standards

by Jasmine Pennic 07/08/2025 Leave a Comment

Certara Expands Partnership with Merck to Streamline Drug Development Data Standards

What You Should Know:  - Certara, a global leader in model-informed drug development, today announced an expanded collaboration with Merck, known as MSD outside of the United States and Canada.  - The strategic agreement will see Merck increase its use of the Certara Pinnacle 21 software platform to include a metadata repository and data standards workflow management. This builds upon Merck’s existing technology collaboration with Certara aimed at aiding regulatory
Read More

Eliminating Cancer Treatment Side-Effects Through Targeted Drug Delivery

by Tim Barrow-Williams, Head of Drug Delivery & Bill Hartman, Pharma and Medtech Design Expert at PA Consulting 06/16/2025 Leave a Comment

Eliminating Cancer Treatment Side-Effects Through Targeted Drug Delivery

Last year, the American Cancer Society predicted that in 2024, the US would reach two million annual new cancer cases for the first time in history. This number is staggering and signifies that cancer is truly a disease that impacts many lives each day.  While not all of these cases result in the grueling treatment associated with chemotherapy and radiation, many of those diagnosed will face the difficult road to recovery. Patients in chemotherapy experience a range of symptoms, from
Read More

Lieber Institute and AWS Collaborate to Optimize Drug Discovery for Brain Disorders

by Fred Pennic 06/10/2025 Leave a Comment

Lieber Institute and AWS Collaborate to Optimize Drug Discovery for Brain Disorders

What You Should Know:  - The Lieber Institute for Brain Development (LIBD) is expanding its technology capabilities on Amazon Web Services (AWS), migrating its IT infrastructure to fully utilize AWS generative AI and compute services to advance its research.  - A recipient of the 2024 AWS IMAGINE Grant, the Institute plans to develop a new tool called GRAPE that combines generative and predictive AI to find new, more effective treatments for brain disorders such as
Read More

Nicoya Lifesciences Acquires Applied Photophysics to Accelerate Drug Discovery

by Syed Hamza Sohail 06/10/2025 Leave a Comment

Nicoya Lifesciences Acquires Applied Photophysics to Accelerate Drug Discovery

What You Should Know: -  Nicoya Lifesciences, Inc., a leading provider of advanced biologics characterization tools for drug discovery and development, today announced its acquisition of Applied Photophysics, a UK-based provider of biophysical characterization instrumentation.  -  Applied Photophysics, bringing a 50-year history of delivering established analytical methods and reliable instrumentation, will now operate as part of Nicoya. Nicoya Expands Biopharmaceutical Analytics
Read More

Kyron.bio Secures $6.2M to Optimize Biologic Drug Development with Precision Glycan Engineering

by Fred Pennic 05/28/2025 Leave a Comment

Kyron.bio Secures $6.2M to Optimize Biologic Drug Development with Precision Glycan Engineering

What You Should Know:  - Biotechnology company kyron.bio announced the successful closing of a $6.2M (€5.5M) seed funding round aimed at solving critical challenges in biologic drug development, specifically varying efficacy and the dangers of side effects.  - The round was led by HCVC, with participation from Verve Ventures, Entrepreneurs First, Saras Capital, and numerous reputable angel investors. - The funds will be used to accelerate the development of kyron.bio’s proprietary
Read More

Cycle Time is the New Currency of Drug Development

by Raj Indupuri, CEO and Co-Founder of eClinical Solutions 05/20/2025 Leave a Comment

Cycle Time is the New Currency of Drug Development

For years, the life sciences industry has been trying to address the same R&D challenges: rising costs, patient recruitment and retention, and difficulty maximizing ROI. Drug development is expensive, and failure rates remain high. Studies estimate the total cost to develop a new drug is between $300 million and nearly $4.5 billion. Meanwhile, clinical trial cycle times continue to lengthen – significantly impacting overall drug development timelines. Clinical trials are increasingly
Read More

Salt AI Partners with Ellison Medical Institute to Advance AI in Cancer Research

by Jasmine Pennic 03/17/2025 Leave a Comment

Salt AI Partners with Ellison Medical Institute to Advance AI in Cancer Research

What You Should Know:  - Salt AI, a company founded by the high-performance computing (HPC) team behind MySpace, is making significant strides in AI-driven drug discovery through its research partnership with the Ellison Medical Institute, led by cancer researcher Dr. David Agus.   - The partnership signifies Salt AI's formal entry into the life sciences sector and has already yielded notable advancements. Key among these is the ability to run AlphaFold2, a foundation model
Read More

Harnessing AI and LLMs to Accelerate Biomedical Discovery for Precision Medicine

by Dr. Rakesh Nagarajan is the Chief Medical Officer at Velsera 01/29/2025 Leave a Comment

Harnessing AI and LLMs to Accelerate Biomedical Discovery for Precision Medicine

The healthcare industry is experiencing a data and technological revolution that is accelerating drug discovery and delivery to patients. Over the past 15 years, we've seen an explosion of targeted therapies — including small molecules, immunotherapies, cell-based treatments, and more — all made possible by the integration of large-scale 'omics data with clinical insights, treatment approaches, and patient outcomes. However, despite these advancements, we still have a long way to go to fully
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 13
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |